Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Published Date: 18 Feb 2023

Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?

2.

A Lot Can Be Said About You by Including Yourself in Photos.

3.

Clinical trial could lead to new 'gold standard' test for prostate cancer detection

4.

What Comes After Cancer?

5.

Taking vitamin D daily decreased cancer mortality, according to a study.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot